July 2022

Myasthenia gravisa: A personal journey

Rashmi Rungta gives an insight into her life with myasthenia gravis – a rare long-term condition that causes muscle weakness.

Acute lymphoblastic leukaemia

Lecturer in Biomedical Science at the University of Salford Tahmina Hussain looks at leukaemia and presents a case study.

My lab: encouraging and supporting research

Professor Stephen Fôn Hughes gives a guided tour of his laboratory in Wrexham, North Wales.

Here to help: enhanced education

Dr Sue Jones, the new IBMS Executive Head of Education, outlines the priorities in her new role.

Miniproteins that launch two-pronged attacks

A new approach developed by researchers at the Indian Institute of Science (IISc) provides an alternative mechanism to vaccines, which renders viruses such as SARS-CoV-2 inactive.

Characteristics of stable vitiligo skin disease

A new study reveals the unique cell-to-cell communication networks that can perpetuate inflammation and prevent repigmentation in patients with vitiligo disease.

An autoimmune cause of schizophrenia?

Researchers from Tokyo Medical and Dental University (TMDU) have identified an autoantibody – a protein that is produced by the immune system to attach to a specific substance from the individual’s own body, rather than to a foreign substance, such as a virus or bacteria – in some patients with schizophrenia.

Covid-19 antibody treatments and new variants

A new paper provides the physical basis for why approved antibody therapeutics are not working in neutralising the recent variants of concern, such as Omicron and its subvariants.

Large-scale data integration

A Chinese research team has proposed a new algorithm (NetMoss) for efficient integration of large-scale microbiome data and biomarker identification.

Genetic test can diagnose immune system disorders

Investigators have used next-generation sequencing to test a DNA panel of 130 different immune system genes from 22 study participants.

Early disease detection using DNA droplets

A group of scientists has developed a computational DNA droplet with the ability to recognise specific combinations of chemically synthesised microRNAs (miRNAs) that act as biomarkers of tumours.

Top